DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Tedisamil

Tedisamil

  • Drug Class Review Beta Adrenergic Blockers

    Drug Class Review Beta Adrenergic Blockers

  • Download Article (PDF)

    Download Article (PDF)

  • ANTIARRHYTHMIC DRUGS Geoffrey W

    ANTIARRHYTHMIC DRUGS Geoffrey W

  • New Antiarrhythmic Agents for Atrial Fibrillation

    New Antiarrhythmic Agents for Atrial Fibrillation

  • TE INI (19 ) United States (12 ) Patent Application Publication ( 10) Pub

    TE INI (19 ) United States (12 ) Patent Application Publication ( 10) Pub

  • Antianginal and Anti-Ischaemic Eycacy of Tedisamil, a Potassium Channel Blocker Heart: First Published As 10.1136/Heart.83.2.167 on 1 February 2000

    Antianginal and Anti-Ischaemic Eycacy of Tedisamil, a Potassium Channel Blocker Heart: First Published As 10.1136/Heart.83.2.167 on 1 February 2000

  • Comparison of the Effects of DC031050, a Class III Antiarrhythmic Agent, on Herg Channel and Three Neuronal Potassium Channels

    Comparison of the Effects of DC031050, a Class III Antiarrhythmic Agent, on Herg Channel and Three Neuronal Potassium Channels

  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum

    A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum

  • Supplemental Data

    Supplemental Data

  • Safety and Efficacy of Intravenously Administered Tedisamil for Rapid

    Safety and Efficacy of Intravenously Administered Tedisamil for Rapid

  • BP501T. MEDICINAL CHEMISTRY – II (Theory)

    BP501T. MEDICINAL CHEMISTRY – II (Theory)

  • Pharmaabkommen A1 E

    Pharmaabkommen A1 E

  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort

    NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort

  • Drug-Induced QT-Interval Prolongation and Proarrhythmic Risk

    Drug-Induced QT-Interval Prolongation and Proarrhythmic Risk

  • Drug Therapy for Preventing Ventricular Arrhythmia in Brugada Syndrome: Do We Have the Answers Yet?

    Drug Therapy for Preventing Ventricular Arrhythmia in Brugada Syndrome: Do We Have the Answers Yet?

  • Antiarrhythmic Drugs.Pdf

    Antiarrhythmic Drugs.Pdf

  • Download PDF File

    Download PDF File

  • Drug Therapy for Atrial Fibrillation

    Drug Therapy for Atrial Fibrillation

Top View
  • The Electrophysiological and Antiarrhythmic Actions
  • Effects of Tedisamil (KC8857) on Cardiac Electrophysiology And
  • KV11.1, Nav1.5, and Cav1.2 Transporter Proteins As Antitarget for Drug Cardiotoxicity
  • Happy 50Th Anniversary of Amiodarone (1969-2019)
  • Convergent Functional Genomic Studies of Omega-3 Fatty Acids in Stress Reactivity, Bipolar Disorder and Alcoholism
  • M Áster En Biotecnología Y Biom Edicina
  • PROPERTIES of DRUG BLOCKADE of a LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL in CULTURED RAT HIPPOCAMPAL NEURONS by XUEPING WANG M.D
  • Early Afterdepolarisation Tendency As a Simulated Pro-Arrhythmic Risk Indicator
  • Relationship Among Amiodarone, New Class III Antiarrhytmics, Miscellaneous Agents and Acquired Long QT Syndrome
  • A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug-Drug Interaction Studies
  • Dronedarone for Prevention of Atrial Fibrillation: an Unfulfilled Promise?
  • Ion Channel Regulation in the Pathophysiology of Atrial Fibrillation: Using
  • Drug-Induced Inhibition and Trafficking Disruption of Ion Channels: Pathogenesis of QT Abnormalities and Drug-Induced Fatal Arrhythmias
  • Analytical Method Development Report for the Determination of Assay & Related Substances of Ibutilide Fumarate in Ibutilide Fumarate Injection
  • Molecular Charge Associated with Antiarrhythmic Actions in a Series of Amino-2- Cyclohexyl Ester Derivatives


© 2024 Docslib.org    Feedback